FR16C0033I2 - Methode de formation de composes d'hydroxypyrone de fer - Google Patents

Methode de formation de composes d'hydroxypyrone de fer

Info

Publication number
FR16C0033I2
FR16C0033I2 FR16C0033C FR16C0033C FR16C0033I2 FR 16C0033 I2 FR16C0033 I2 FR 16C0033I2 FR 16C0033 C FR16C0033 C FR 16C0033C FR 16C0033 C FR16C0033 C FR 16C0033C FR 16C0033 I2 FR16C0033 I2 FR 16C0033I2
Authority
FR
France
Prior art keywords
formation
iron hydroxypyrone
hydroxypyrone compounds
iron
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR16C0033C
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shield Tx UK Ltd
Original Assignee
Shield Tx UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shield Tx UK Ltd filed Critical Shield Tx UK Ltd
Publication of FR16C0033I1 publication Critical patent/FR16C0033I1/fr
Application granted granted Critical
Publication of FR16C0033I2 publication Critical patent/FR16C0033I2/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/40—Oxygen atoms attached in positions 3 and 4, e.g. maltol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compounds Of Iron (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR16C0033C 2002-05-18 2016-08-09 Methode de formation de composes d'hydroxypyrone de fer Active FR16C0033I2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0211500.4A GB0211500D0 (en) 2002-05-18 2002-05-18 Method of forming iron hydroxypyrone compounds
PCT/GB2003/001956 WO2003097627A1 (en) 2002-05-18 2003-05-07 Method of forming iron hydroxypyrone compounds

Publications (2)

Publication Number Publication Date
FR16C0033I1 FR16C0033I1 (enrdf_load_stackoverflow) 2016-09-23
FR16C0033I2 true FR16C0033I2 (fr) 2018-01-19

Family

ID=9936987

Family Applications (1)

Application Number Title Priority Date Filing Date
FR16C0033C Active FR16C0033I2 (fr) 2002-05-18 2016-08-09 Methode de formation de composes d'hydroxypyrone de fer

Country Status (11)

Country Link
US (1) US7459569B2 (enrdf_load_stackoverflow)
EP (1) EP1506183B1 (enrdf_load_stackoverflow)
AT (1) ATE352547T1 (enrdf_load_stackoverflow)
AU (1) AU2003233881A1 (enrdf_load_stackoverflow)
BE (1) BE2016C041I2 (enrdf_load_stackoverflow)
CA (1) CA2483067C (enrdf_load_stackoverflow)
DE (1) DE60311456T2 (enrdf_load_stackoverflow)
ES (1) ES2283771T3 (enrdf_load_stackoverflow)
FR (1) FR16C0033I2 (enrdf_load_stackoverflow)
GB (1) GB0211500D0 (enrdf_load_stackoverflow)
WO (1) WO2003097627A1 (enrdf_load_stackoverflow)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8952061B2 (en) * 2006-08-22 2015-02-10 University Of Virginia Patent Foundation Methods and compounds regulating the erythroid response to iron deficiency
GB2451713B (en) 2007-02-06 2009-12-16 Medical Res Council Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation
GB0808835D0 (en) 2008-05-15 2008-06-18 Vitra Pharmaceuticals Ltd Therapeutic compositions
US8536106B2 (en) 2010-04-14 2013-09-17 Ecolab Usa Inc. Ferric hydroxycarboxylate as a builder
GB201101370D0 (en) 2011-01-27 2011-03-09 Iron Therapeutics Holdings Ag Process
GB201404390D0 (en) * 2014-03-12 2014-04-23 Iron Therapeutics Holdings Ag Composition
WO2015198304A1 (en) 2014-06-22 2015-12-30 Dexcel Pharma Technologies Ltd. Pharmaceutical compositions comprising ferric citrate and methods for the production thereof
GB2531742B (en) * 2014-10-28 2016-10-05 Iron Therapeutics Holdings Ag Polymorphs of ferric maltol
GB201517893D0 (en) 2015-10-09 2015-11-25 Medical Res Council Methods for producing carboxylate ligand modified ferric iron hydroxide colloids
WO2017167963A1 (en) * 2016-03-31 2017-10-05 Medical Research Council Methods for producing ferric maltol compositions from ligand modified and ligand coated ferric hydroxides
AU2017242906B2 (en) * 2016-03-31 2020-11-19 Shield TX (UK) Limited Methods for producing Ferric maltol compositions from Ferrous Hydroxides
US11406664B2 (en) 2016-03-31 2022-08-09 Shield TX (UK) Limited Ferric maltol compositions for use in the treatment or prevention of cancer and tumours
US11155529B2 (en) 2016-03-31 2021-10-26 Shield TX (UK) Limited Methods for producing ferric maltol compositions from elemental iron
GB202005054D0 (en) 2020-04-06 2020-05-20 Nemysis Ltd Carboxylate Ligand Modified Ferric Iron Hydroxide Compositions for Use in the Treatment or Prevention of Iron Deficiency Associated with Liver Diseases
CN112574158B (zh) * 2020-12-29 2022-08-02 南京百泽医药科技有限公司 一种麦芽酚铁晶型ii及其制备方法
CN115177625A (zh) * 2022-06-28 2022-10-14 金陵药业股份有限公司 一种羧基麦芽糖铁药用组合物及其制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3130204A (en) * 1962-02-07 1964-04-21 Pfizer & Co C Preparation of gamma-pyrones
FR1500765A (fr) * 1963-09-19 1967-11-10 Pfizer & Co C Dérivés de l'acide pyroméconique et procédé pour leur préparation
SE322866B (enrdf_load_stackoverflow) * 1966-12-15 1970-04-20 Astra Ab
US4018907A (en) * 1975-08-25 1977-04-19 General Foods Corporation Coloring food with iron-complexes
US4212685A (en) * 1978-12-11 1980-07-15 Lea Manufacturing Company Protective and color receptive coating for aluminum
US4279936A (en) * 1979-09-24 1981-07-21 William Underwood Company Maltol treated canned meat process
DE3365971D1 (en) * 1982-03-24 1986-10-16 Nat Res Dev Pharmaceutical compositions containing a complex of iron with n-substituted 3-hydroxypyrid-2-one or -4-one derivatives
GR78491B (enrdf_load_stackoverflow) 1982-03-24 1984-09-27 Nat Res Dev
GB2128998B (en) * 1982-10-22 1986-07-16 Nat Res Dev Pharmaceutical compositions of iron complexes of 3 hydroxy-4-pyrone
GB8308054D0 (en) * 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
GB8308055D0 (en) * 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
GB8325494D0 (en) 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
US4912118A (en) 1983-09-23 1990-03-27 National Research Development Corporation Pharmaceutical compositions
USRE34313E (en) 1983-09-23 1993-07-13 National Research Development Corporation Pharmaceutical compositions
GB8325496D0 (en) * 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
GB8329043D0 (en) * 1983-10-31 1983-11-30 Hider R C Pharmaceutical compositions
GB8410290D0 (en) 1984-04-19 1984-05-31 Callingham B A Pharmaceutical compositions
US5177068A (en) 1984-04-19 1993-01-05 National Research Development Corporation Pharmaceutical compositions
GB8410289D0 (en) 1984-04-19 1984-05-31 Callingham B A Pharmaceutical compositions
GB8606913D0 (en) 1986-03-20 1986-04-23 Hider R C Treatment of sickle cell disease
JPH0367565A (ja) 1989-08-07 1991-03-22 Kansai Paint Co Ltd 鉄分強化食品
GB9209078D0 (en) 1992-04-27 1992-06-10 Hider Robert C Pharmaceutical compositions
GB9217099D0 (en) 1992-08-12 1992-09-23 British Tech Group Pharmaceutical compositions
WO1996041627A2 (en) 1995-06-10 1996-12-27 Vitra Pharmaceuticals Ltd Iron compounds, compositions, methods of making the same and uses thereof
GB9621273D0 (en) 1996-10-11 1996-11-27 Cortecs Ltd Therapeutic method

Also Published As

Publication number Publication date
CA2483067C (en) 2011-04-26
EP1506183A1 (en) 2005-02-16
ATE352547T1 (de) 2007-02-15
GB0211500D0 (en) 2002-06-26
US20050250754A1 (en) 2005-11-10
DE60311456T2 (de) 2007-11-15
AU2003233881A1 (en) 2003-12-02
WO2003097627A1 (en) 2003-11-27
US7459569B2 (en) 2008-12-02
DE60311456D1 (de) 2007-03-15
FR16C0033I1 (enrdf_load_stackoverflow) 2016-09-23
ES2283771T3 (es) 2007-11-01
BE2016C041I2 (enrdf_load_stackoverflow) 2022-08-09
EP1506183B1 (en) 2007-01-24
CA2483067A1 (en) 2003-11-27

Similar Documents

Publication Publication Date Title
FR16C0033I2 (fr) Methode de formation de composes d'hydroxypyrone de fer
DK1307576T3 (da) Fortyndet syre/metalsalt-hydrolyse af lignocelluloser
CY1108593T1 (el) Συμπυκνωμενο υδατικο διαλυμα αμβροξολης
EP1141444A4 (en) NEW COMPOSITION FOR SELECTIVE ETCHING OF OXIDES ON METALS
MXPA03000510A (es) Sales estables de acido o-acetilsalicilico con aminoacidos basicos.
TW200504058A (en) Method for preparing fused oxazinones
TR199902759T2 (xx) Sertindole �retimi i�in bir y�ntem
TR200100016T2 (tr) Hidroksimetiltiobütirik asitin hazırlanmasına yönelik metod
PL365213A1 (en) Enteric ketoacid salts and amino acids
WO2002024001A3 (de) Tierfuttersupplement enthaltend d-pantothensäure und/oder deren salze, verbessertes verfahren zu dessen herstellung sowie dessen verwendung
NZ530173A (en) Method for producing an essentially chlorite-free, stable, aqueous chlorine-oxygen solution, the chlorine-oxygen solution obtained by means of said method, and the use of the same
IL157402A0 (en) Method for producing d-pantothenic acid and/or salts therefor as an additive for animal feed
AU2002250978A1 (en) Method for producing D-pantothenic acid and/or salts thereof as an additive for animal feed
NO20001070D0 (no) Diureider og deres anvendelse
WO2003035636A3 (en) Process for the preparation of 3 - isochromanone
IT1291673B1 (it) Processo per la preparazione di 1,4,7,10 - tetraazaciclododecano
WO2002066663A3 (de) Verfahren zur herstellung von d-pantothensäure und/oder deren salze als zusatz zu tierfuttermitteln
EA200200783A2 (ru) Почвоулучшитель и средство для витализации воды
NZ334940A (en) process of producing 4-(des-dimethylamino)-tetracycline
ATE374764T1 (de) Basisches salz von thiooctansäure mitl-carnitin
AU2001249606A1 (en) Method of cyanide salt production
WO2003051297A3 (en) Aqueous ifosfamide composition
RU2000109795A (ru) Способ получения магнитоактивного соединения
FR2816954B1 (fr) Solution aqueuse boree, realiser a partir d'un compose d'acide borique et de carbonate de sodium
IL160162A0 (en) Salts of substituted 1,2,3,4,-tetrahydroisoquinolie-2-carboxylic acid derivatives